HR 1613
118th Congress
House
Health
Business records
Congressional oversight
Government information and archives
Health care costs and insurance
Home and outpatient care
Inflation and prices
Medicaid
Prescription drugs
Public contracts and procurement
Retail and wholesale trades
State and local government operations
User charges and fees
Drug Price Transparency in Medicaid Act of 2023
Introduced: March 17, 2023
Introduced by:
Carter, Earl L. "Buddy"
Republican
· Georgia
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 24, 2023
Referred to the Subcommittee on Health.
Mar 17, 2023
Referred to the House Committee on Energy and Commerce.
Mar 17, 2023
Introduced in House
Plain-English summary
Drug Price Transparency in Medicaid Act of 2023
This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions and survey participation to be made publicly available.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2